301207.SZ

Hualan Biological Bacterin Inc. 301207.SZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 301207.SZ 300841.SZ 688366.SS 688319.SS 688513.SS 688639.SS 688076.SS 600645.SS 605116.SS 300294.SZ
6M 28.98 % 20.82 % -5.63 % 45.70 % 47.16 % 13.52 % 5.67 % 13.45 % 5.66 % -11.31 %
YTD 17.82 % 44.98 % -14.65 % 124.44 % 83.40 % 0.74 % 2.02 % 23.50 % 7.52 % -17.83 %
1Y 4.65 % 19.68 % -28.94 % 121.11 % 47.12 % -15.12 % -19.98 % 12.24 % -3.76 % -26.17 %
3Y -38.56 % -12.93 % -1.98 % 55.47 % 33.29 % -49.60 % 146.01 % 35.05 % -9.19 % -26.17 %
5Y -57.26 % -65.77 % -40.25 % -40.15 % 44.62 % 85.81 % -53.08 % -5.08 % 7.73 % -41.01 %
10Y -57.26 % 69.32 % -46.33 % -40.15 % 7.12 % 85.81 % -53.08 % -55.00 % 82.82 % -4.80 %
From the beginning -57.26 % 69.32 % -46.33 % -40.15 % 7.12 % 85.81 % -53.08 % 480.75 % 82.82 % 182.83 %

Dividend

Hualan Biological Bacterin Inc.

Chengdu Kanghua Biological Products Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd.

Chengdu Olymvax Biopharmaceuticals Inc.

Chengdu Easton Biopharmaceuticals Co., Ltd.

Anhui Huaheng Biotechnology Co., Ltd.

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Vcanbio Cell & Gene Engineering Corp., Ltd

Aurisco Pharmaceutical Co.,Ltd.

China Resources Boya Bio-pharmaceutical Group Co., Ltd.